Cancer and Metastasis Reviews

Papers
(The H4-Index of Cancer and Metastasis Reviews is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Immunotherapy for leptomeningeal disease from solid tumors: current clinical outcomes and future opportunities351
Editorial Expression of Concern: Targeting microRNAs as a promising anti-cancer therapeutic strategy against traffic-related air pollution-mediated lung cancer213
CAR T-cell therapy for B-cell lymphomas: outcomes and resistance mechanisms202
Obesity and cancer140
Clonal tracking in cancer and metastasis132
Regulation of dormancy during tumor dissemination: the role of the ECM113
The impact of tumor microenvironment: unraveling the role of physical cues in breast cancer progression103
The functions and modifications of tRNA-derived small RNAs in cancer biology91
New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions84
The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer68
Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?67
Targeting lipid metabolism in cancer: neuroblastoma67
CAR T-cell therapy to treat multiple myeloma: current state and future directions61
KISS1 metastasis suppressor in tumor dormancy: a potential therapeutic target for metastatic cancers?59
p73 isoforms meet evolution of metastasis58
Cell-cell interactions mediating primary and metastatic breast cancer dormancy55
Healthcare disparities, screening, and molecular testing in the changing landscape of non–small cell lung cancer in the United States: a review53
TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond47
Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives45
Biography—Mathieu Boissan, Pharm.D., Ph.D45
Preface42
Targeting microRNAs as a promising anti-cancer therapeutic strategy against traffic-related air pollution-mediated lung cancer40
Neuropeptide Y in cancer—biological functions and potential clinical implications40
Biographies38
LGR5: An emerging therapeutic target for cancer metastasis and chemotherapy resistance38
Role of Neuropilin-2-mediated signaling axis in cancer progression and therapy resistance36
The multifaceted mechanisms of malignant glioblastoma progression and clinical implications36
The role of cancer cell bioenergetics in dormancy and drug resistance35
Clusterin: a marker and mediator of chemoresistance in colorectal cancer35
Cross-talk between the microbiome and chronic inflammation in esophageal cancer: potential driver of oncogenesis35
Short-chain fatty acids in cancer pathogenesis35
How circulating tumor cluster biology contributes to the metastatic cascade: from invasion to dissemination and dormancy35
Immunomodulatory role of oncogenic alterations in non-small cell lung cancer: a review of implications for immunotherapy35
Tumor necrosis factor superfamily signaling: life and death in cancer34
Helicobacter pylori–activated fibroblasts as a silent partner in gastric cancer development34
0.29285192489624